Acarix AB (publ) brings forward publication of interim report for fourth quarter to February 17, 2022
Press release Malmö, Sweden, February 9, 2022 Acarix AB (publ) brings forward publication of interim report for ...
Acarix invites to virtual Capital Market Day
Press releaseMalmö, Sweden, February 7, 2022 Acarix invites to virtual Capital Market Day Acarix is stepping up commercializa...
Acarix appoints US based Helen Ljungdahl Round as new CEO
Press release (MAR)Malmö, Sweden, January 10, 2022 Acarix appoints US based Helen Ljungdahl Round as new CEO The Board of Acarix...
Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue
Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed ...
Acarix announce final outcome in rights issue
Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Company") has c...
Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million
Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Announcement from Acarix’s extra general meeting
Press release Malmö, November 23, 2021 Announcement from Acarix's extra general meeting The extra general meeting of Acarix AB (...
Acarix AB (publ) publishes Interim Report, January – September 2021
Press release Malmö, November 11, 2021 Acarix AB (publ) publishes Interim Report, January – September 2021 Positive trend ...
Acarix accelerates US market entry with Proximo Medical as commercialization partner
Press release (MAR)Malmö, Sweden, November 9, 2021 Acarix accelerates US market entry with Proximo Medical as commerciali...
Acarix US expansion to be a major contributor to the company’s new financial and operational goals
Press release (MAR)Malmö, Sweden, November 8, 2021 Acarix US expansion to be a major contributor to the company’s new fina...
Notice of Extra General Meeting in Acarix AB
Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened...
Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 million to expand on the US market
Press release (MAR) Malmö, Sweden, November 5, 2021 Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 ...